Gaudium IVF IPO
₹75 – ₹75 · Issue Size ₹165 CrIPO Overview
Business Model
- Patient Centric Approach: Every patient is unique and to be treated accordingly with care and support. We have
- Expert Team: Our Company was founded by Dr. Manika Khanna and Dr. Peeyush Khanna, infertility expert with
- Embryologist to perform the complex IVF treatment where the patient is treated with due care and emotion.
- Modern Technology: We provide world class treatment by utilising latest technology, like advantage of next-
IPO Timeline
Objects of the Issue
The Issue comprises of a Fresh Issue by the company and an Offer for Sale by the Promoter Selling Shareholder. a) The Offer for Sale The Promoter Selling Shareholder proposes to sell up to 94,93,700 Equity Shares held by her, aggregating up to ₹ lakhs. the company will not receive any proceeds of the Offer for Sale by the Promoter Selling Shareholder.
| Purpose | Amount |
|---|---|
| Total borrowings have increased from in fiscal 2023 to 2,251.37 lakhs for the period ended September | ₹9.78 Cr |
| However, under the company’s credit scheme, only 20% of the total revenue Average Rs per case is collected | ₹0.02 Cr |
| As on date, we have contingent liabilities of including interest thereon on vis-a-vis net worth | ₹44.99 Cr |
| Dispute Redressal Commission - IX East. The Complainant has demanded alleging wrongful | ₹0.5 Cr |
Risk Factors
Wednesday, February 18, 2026
Strengths & Weaknesses
Strengths
- Patient Centric Approach: Every patient is unique and to be treated accordingly with care and support. We have
- Expert Team: Our Company was founded by Dr. Manika Khanna and Dr. Peeyush Khanna, infertility expert with
- Embryologist to perform the complex IVF treatment where the patient is treated with due care and emotion.
- Modern Technology: We provide world class treatment by utilising latest technology, like advantage of next-
Management & Promoters
Peer Comparison
| Company | P/E | EPS |
|---|---|---|
| Gaudium IVF IPO | — | — |
| Dated: February | 13.0x | — |
| Please read section of the Companies Act | 32.0x | — |
Pre-IPO Financials
| Period | Revenue (Cr) | PAT (Cr) | Net Worth (Cr) | Total Assets (Cr) |
|---|---|---|---|---|
| February 2023 | — | ₹0.01 Cr | ₹0.03 Cr | — |
| October 2024 | — | ₹0.02 Cr | ₹0.21 Cr | — |
| August 2025 | — | — | ₹0.39 Cr | — |
| March 2025 | — | — | ₹0.39 Cr | — |
| April 2023 | — | — | ₹0.54 Cr | — |
About
Gaudium IVF, founded in March 2015, is one of the leading companies offering In Vitro Fertilization (IVF) treatments for women across India. The company operates its business over 30 locations, with seven hubs (centres) and twenty-eight spokes. The firm treats its patients in various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman. The firm offers various fertility services such as Vitro Fertilisation (IVF), intracytoplasmic sperm injection (ICSI
Key Regulations and Policies", "History and Certain Corporate Matters", "Restated Consolidated Financial Information", "Financial Indebtedness", "Outstanding Litigation and Material Developments", "Offer Procedure" and
| Exchange | NSE |
| Issue Type | mainboard |
| Face Value | ₹5 per share |
Documents
rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.